Sunday, 6 June 2021

Inside a plant in China producing the WHO-approved Sinovac Covid-19 vaccine


South China Morning Post shows that the WHO approval of Sinovac Biotech’s coronavirus vaccine for emergency use on June 1, 2021, will help ease the global vaccine shortage. Sinovac Biotech has already distributed more than 600 million doses of its CoronaVac vaccine to nearly 40 countries, as of May 31, 2021. It uses an inactivated virus to trigger a protective immune response, unlike vaccines from companies like BioNTech, which feature newer mRNA technology. The Post takes a look inside their Beijing plant.
at

2 comments:

  1. Wulan Dari13 June 2021 at 20:29

    Very nice post, i certainly love this website, keep on it

    Nexxtlab.lu
    Information
    Click Here
    Visit Web

    ReplyDelete
    Replies
    1. Igor B17 June 2021 at 11:09

      Thanks for enjoying the web site.

      China has really reported the first-known human case of H10N3, an uncommon strain of avian flu that is typically only found in wild birds and waterfowl in Asia.

      The infection was detected in a 41-year-old man on May 28, one month after he was admitted to hospital for a fever and other symptoms in Zhenjiang, in the eastern province of Jiangsu.

      Delete